Cell reprogramming

Expectations and challenges for chemistry in stem cell biology and regenerative medicine

L. Anastasia, G. Pelissero, B. Venerando, G. Tettamanti

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The possibility of reprogramming adult somatic cells into pluripotent stem cells (iPSCs) has generated a renewed interest into stem cell research and promises to overcome several key issues, including the ethical concerns of using human embryonic stem cells and the difficulty of obtaining large numbers of adult stem cells (Belmonte et al., Nat Rev Genet, 2009). This approach is also not free from challenges like the mechanism of the reprogramming process, which has yet to be elucidated, and the warranties for safety of generated pluripotent cells, especially in view of their possible therapeutic use. Very recently, several new reprogramming methods have surfaced, which seem to be more appropriate than genetic reprogramming. Particularly, chemically induced pluripotent cells (CiPSs), obtained with recombinant proteins or small synthetic molecules, may represent a valid approach, simpler and possibly safer than the other ones.

Original languageEnglish
Pages (from-to)1230-1237
Number of pages8
JournalCell Death and Differentiation
Volume17
Issue number8
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Regenerative Medicine
Cell Biology
Stem Cells
Viverridae
Stem Cell Research
Pluripotent Stem Cells
Adult Stem Cells
Therapeutic Uses
Recombinant Proteins
Ethics
Safety
Cellular Reprogramming

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Medicine(all)

Cite this

Cell reprogramming : Expectations and challenges for chemistry in stem cell biology and regenerative medicine. / Anastasia, L.; Pelissero, G.; Venerando, B.; Tettamanti, G.

In: Cell Death and Differentiation, Vol. 17, No. 8, 08.2010, p. 1230-1237.

Research output: Contribution to journalArticle

@article{76ac5084438745cf9dd60248d35116b6,
title = "Cell reprogramming: Expectations and challenges for chemistry in stem cell biology and regenerative medicine",
abstract = "The possibility of reprogramming adult somatic cells into pluripotent stem cells (iPSCs) has generated a renewed interest into stem cell research and promises to overcome several key issues, including the ethical concerns of using human embryonic stem cells and the difficulty of obtaining large numbers of adult stem cells (Belmonte et al., Nat Rev Genet, 2009). This approach is also not free from challenges like the mechanism of the reprogramming process, which has yet to be elucidated, and the warranties for safety of generated pluripotent cells, especially in view of their possible therapeutic use. Very recently, several new reprogramming methods have surfaced, which seem to be more appropriate than genetic reprogramming. Particularly, chemically induced pluripotent cells (CiPSs), obtained with recombinant proteins or small synthetic molecules, may represent a valid approach, simpler and possibly safer than the other ones.",
author = "L. Anastasia and G. Pelissero and B. Venerando and G. Tettamanti",
year = "2010",
month = "8",
doi = "10.1038/cdd.2010.14",
language = "English",
volume = "17",
pages = "1230--1237",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Cell reprogramming

T2 - Expectations and challenges for chemistry in stem cell biology and regenerative medicine

AU - Anastasia, L.

AU - Pelissero, G.

AU - Venerando, B.

AU - Tettamanti, G.

PY - 2010/8

Y1 - 2010/8

N2 - The possibility of reprogramming adult somatic cells into pluripotent stem cells (iPSCs) has generated a renewed interest into stem cell research and promises to overcome several key issues, including the ethical concerns of using human embryonic stem cells and the difficulty of obtaining large numbers of adult stem cells (Belmonte et al., Nat Rev Genet, 2009). This approach is also not free from challenges like the mechanism of the reprogramming process, which has yet to be elucidated, and the warranties for safety of generated pluripotent cells, especially in view of their possible therapeutic use. Very recently, several new reprogramming methods have surfaced, which seem to be more appropriate than genetic reprogramming. Particularly, chemically induced pluripotent cells (CiPSs), obtained with recombinant proteins or small synthetic molecules, may represent a valid approach, simpler and possibly safer than the other ones.

AB - The possibility of reprogramming adult somatic cells into pluripotent stem cells (iPSCs) has generated a renewed interest into stem cell research and promises to overcome several key issues, including the ethical concerns of using human embryonic stem cells and the difficulty of obtaining large numbers of adult stem cells (Belmonte et al., Nat Rev Genet, 2009). This approach is also not free from challenges like the mechanism of the reprogramming process, which has yet to be elucidated, and the warranties for safety of generated pluripotent cells, especially in view of their possible therapeutic use. Very recently, several new reprogramming methods have surfaced, which seem to be more appropriate than genetic reprogramming. Particularly, chemically induced pluripotent cells (CiPSs), obtained with recombinant proteins or small synthetic molecules, may represent a valid approach, simpler and possibly safer than the other ones.

UR - http://www.scopus.com/inward/record.url?scp=77954656717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954656717&partnerID=8YFLogxK

U2 - 10.1038/cdd.2010.14

DO - 10.1038/cdd.2010.14

M3 - Article

VL - 17

SP - 1230

EP - 1237

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 8

ER -